Debut Plus

461.7

-7.08 -1.51%

17 Jul 2026

NSE Listed

Eureka Forbes Limited (EUREKAFORB)

Volume: 1,07,442Avg Vol 1W: 1,84,660Avg Vol 1M: 1,88,460.152W Range:403.2668.3
Key Ratios
Checked 5h ago
Market Cap₹9,067 Cr
Current Price₹461.7
Previous Close₹468.78
High / Low (52w)₹668.3 / ₹403.2
Volume1,07,442
Avg Vol (1W)1,84,660
Avg Vol (1M)1,88,460.1
Stock P/E178.93
Book Value₹237.78
Dividend Yield0%
ROE418.3%
ROA241.5%
Revenue (TTM)₹2,451 Cr
Revenue Growth11.3%
Profit Margin6%
Total Debt₹0 Cr
Shares Outstanding19 Cr
Face Value₹10
EPS (TTM)₹9.95
P/B1.98
Debt / Equity0.01
50 DMA₹459.63
200 DMA₹519.93
Day change-1.51%
Price Chart
461.7 18.29% · 1Y
65342647.5L
2025-07-17
2026-07-16

20-day avg volume: 1.9L shares

Pros
  • Healthy return on equity of 418.3%.
  • Company is almost debt-free.
  • Revenue grew 108% YoY.
Cons
  • Company is loss-making at the latest annual result.
  • Stock trades at a high P/E of 179.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹553 Cr₹673 Cr₹598 Cr₹613 Cr₹608 Cr₹772 Cr₹645 Cr₹684 Cr
EBITDA₹45 Cr₹62 Cr₹49 Cr₹66 Cr₹53 Cr₹87 Cr₹57 Cr₹70 Cr
Net Profit₹32 Cr₹48 Cr₹35 Cr₹50 Cr₹39 Cr₹63 Cr₹10 Cr₹51 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹16 Cr₹8 Cr₹384 Cr₹2,095 Cr₹2,198 Cr₹2,451 Cr
EBITDA₹0 Cr₹-1 Cr₹11 Cr₹99 Cr₹153 Cr₹222 Cr
Net Profit₹-1 Cr₹-2 Cr₹3 Cr₹27 Cr₹96 Cr₹164 Cr
EPS-2.22-3.380.721.374.938.46
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹10 Cr₹7 Cr₹6,127 Cr₹6,030 Cr₹6,129 Cr₹6,338 Cr
Total Liabilities₹8 Cr₹7 Cr₹2,050 Cr₹1,932 Cr₹1,903 Cr₹1,928 Cr
Equity₹2 Cr₹0 Cr₹4,077 Cr₹4,099 Cr₹4,227 Cr₹4,410 Cr
Total Debt₹0 Cr
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹0 Cr₹38 Cr₹187 Cr₹196 Cr₹241 Cr
Investing₹0 Cr₹-4 Cr₹-26 Cr₹-32 Cr₹-168 Cr
Financing₹0 Cr₹-31 Cr₹-154 Cr₹-120 Cr₹-43 Cr
Free Cash Flow₹0 Cr₹38 Cr₹187 Cr₹196 Cr₹241 Cr
Shareholding
Promoter 62.56% Institutions 19.82% Public 17.63%
Efficiency & Working Capital
ROCE5.5%
Interest Coverage40.2
Dividend Payout
Debtor Days27 d
Inventory Days38 d
Payable Days27 d
Cash Conversion Cycle37 d
Working Capital Days65 d
Shareholding Details

As of 2026-03-31

Promoter62.6%
FII13.7%
DII6.2%
Institutions19.8%
Public17.6%
Promoter Pledge53.7%
No. of Shareholders35,383
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters72.6%72.6%72.6%62.6%62.6%62.6%62.6%62.6%62.6%62.6%62.6%62.6%
FIIs10.8%10.6%10.8%16%13.2%12.6%12.6%12.5%14%13.7%13.9%13.7%
DIIs2.7%3.4%4%5.6%6.3%6.7%6.6%7%6.4%6.4%6.4%6.2%
Public13.9%13.4%12.7%15.8%17.9%18.1%18.3%17.9%17.1%17.3%17.1%17.6%
Promoter Pledge100%100%100%100%53.7%53.7%53.7%53.7%53.7%53.7%53.7%53.7%
No. of Shareholders14,83615,83821,84326,75128,11531,62832,45330,68329,63831,45934,15935,383
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202503
Major Shareholders (>1%)
NameCategoryStakeShares
Lunolux LimitedShareholding of Promoter and Promoter Group62.6%12.10 Cr
Hill Fort India Fund LpPublic Shareholding2.1%39,66,277
Goldman Sachs Funds - Goldman Sachs India Equity PortfolioPublic Shareholding1.8%34,07,267
Pari Washington India Master Fund, Ltd.Public Shareholding1.5%29,36,782
Whiteoak Capital Flexi Cap FundPublic Shareholding1%20,09,484
Mr. Homi Katgara (independent Director)Public Shareholding0%10,000
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Lunolux Limited6.50 Cr53.7%2026-03-31
Whiteoak Capital Flexi Cap Fund00%2026-03-31
Pari Washington India Master Fund, Ltd.00%2026-03-31
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio00%2026-03-31
Hill Fort India Fund Lp00%2026-03-31
Mr. Homi Katgara (independent Director)00%2026-03-31
Lunolux Limited6.50 Cr53.7%2025-12-31
Hill Fort India Fund Lp00%2025-12-31
Goldman Sachs Funds - Goldman Sachs India Equity Portfolio00%2025-12-31
Pari Washington India Master Fund, Ltd.00%2025-12-31
Mr. Homi Katgara (independent Director)00%2025-12-31
Lunolux Limited6.50 Cr53.7%2025-09-30
Board of Directors
NameDesignationYear
Arvind UppalChairman(Non Exe)&Dir(Non-Ind)2025
Pratik PotaManaging Director & CEO2025
Sahil DalalNon-Exec & Non-Independent Dir2025
Vinod RaoIndependent Non Exe. Director2025
Gurveen SinghIndependent Non Exe. Director2025
HOMI ADI KATGARAIndependent Non Exe. Director2025
Shashank Shankar SamantIndependent Non Exe. Director2025
Shilpa JainCompany Secretary / Compliance Officer2025
Segments — Product
SegmentRevenueShare
Business of Health, Hygiene product₹0 Cr
Segments — Geography
RegionRevenueShare
India₹2,435 Cr100%
Outside India₹1 Cr0%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2025₹10250193193
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
2025430092376
2025420092375
2025100001
Insider / Designated-Person Trades

30 recent disclosure(s)

Mr. Satish Kumar SatyarthiDisposal · 5,659
Mr. Satish Kumar SatyarthiAcquisition · 5,659
Mr. Satish Kumar SatyarthiDisposal · 6,917
Mr. Satish Kumar SatyarthiAcquisition · 6,917
Mr. Vivek Kumar SharmaDisposal · 10,000
Kumkum DheerDisposal · 54,000
Substantial Acquisitions (SAST)

10 disclosure(s)

Market29/08/2024 · 38,67,527
Market13/08/2024 · 42,32,180
Market11/06/2024 ·
Creation Of Encumbrance07/05/2024 ·
Creation Of Encumbrance07/05/2024 ·
Creation Of Encumbrance07/05/2024 ·
Company Information
Incorporated2008
ChairmanArvind Uppal
AuditorDeloitte Haskins & Sells LLP
Investor Email[email protected]; dshinde@eurekaforbes.
🌐 www.eurekaforbes.com

📍 B1/B2 7th 701 Marath Innova, Kadam Marg Lawer Parel, Mumbai, Maharashtra, 400013

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search